URM1 antibodies are immunological reagents designed to detect and quantify URM1, a ubiquitin-like protein (UBL) that functions as a sulfur carrier for tRNA modification and covalently conjugates to target proteins during oxidative stress . These antibodies are critical for:
Identifying URM1-protein conjugates (urmylation) in stress response pathways .
Studying URM1’s role in tRNA 2-thiolation, which optimizes ribosomal translation .
Analyzing URM1’s association with cancer progression and apoptosis .
Key commercially available URM1 antibodies include:
Key Validation Results:
ab110699: Detects recombinant URM1 at 0.01 µg and endogenous URM1 in HepG2 lysates .
15285-1-AP: Validated in WB (human placenta, A549 cells) and IHC (mouse liver) .
URM1 antibodies confirm its thiocarboxylated form (-COSH), which donates sulfur for tRNA wobble uridine modification (mcm⁵s²U) .
Oxidative stress (e.g., diamide, H₂O₂) induces URM1 conjugation to substrates like Ahp1 and USP15, detectable via WB .
Knockdown studies using URM1-targeting shRNA revealed cytokinesis defects in HeLa cells, including multinucleation and >4n DNA content .
Liver Cancer: High URM1 expression correlates with poor prognosis in hepatocellular carcinoma (HCC). URM1 knockdown suppresses proliferation, migration, and tumor growth in xenograft models .
Toxoplasma gondii: URM1 deletion reduces parasite virulence and stress tolerance, highlighting its role in pathogen survival .
URM1 knockdown upregulates phosphorylated JNK1/2 and p53, promoting apoptosis in liver cancer cells .
Table: URM1 Knockdown Effects in HCC (n=90)
| Parameter | URM1 High vs. Low | P-value |
|---|---|---|
| Tumor size | Larger | <0.01 |
| Survival rate | Reduced | <0.05 |
| Apoptosis markers | Increased | <0.01 |
Methodological approach:
Perform siRNA/shRNA-mediated URM1 knockdown (≥95% reduction) in target cell lines (e.g., HeLa, U2OS) and compare band intensity between control and knockdown lysates .
Use recombinant URM1 protein (11 kDa theoretical size) as a positive control to confirm antibody reactivity at the expected molecular weight .
Validate cross-reactivity across species using lysates from human, mouse, and rat tissues, as URM1 is evolutionarily conserved .
Key considerations:
Integrated methodology:
Functional proteomics: Use URM1 vinyl methylester (VME) probes to covalently trap interacting enzymes (e.g., ATPBD3, MOCS3) in HEK293T lysates, followed by LC-MS/MS .
Oxidative stress assays: Perform Western blotting with anti-URM1 under diamide/H₂O₂ treatment to detect UBL-conjugates (e.g., Ahp1 modification) .
tRNA analysis: Combine antibody-based immunoprecipitation with mass spectrometry to quantify 2-thiolation levels at mcm⁵S²U wobble positions .
Technical safeguards:
Case analysis:
Workflow integration:
Ubiquitinome profiling: Immunoprecipitate URM1 conjugates from diamide-treated cells, identify targets via LC-MS/MS (e.g., Ahp1, CAS) .
tRNA sequencing: Compare ΔUrm1 vs. wild-type strains to quantify wobble uridine thiolation (requires ≥50× coverage) .
Structural biology: Use antibody-guided crosslinking to map URM1’s interaction interface with MOCS3/ATPBD3 .
Resolution framework:
Species differences: Human cells exhibit cytokinesis failure , while T. gondii survives with attenuated virulence .
Stress conditions: URM1 is dispensable under standard culture but critical under oxidative stress (e.g., 1.5 mM diamide reduces ΔUrm1 survival by 70%) .
Functional redundancy: Thioredoxin systems may compensate in certain cell types (e.g., DF-1 fibroblasts ).
Optimization checklist:
Lysis buffer: Include 20 mM N-ethylmaleimide to preserve thioester bonds .
Electrophoresis: Use 4–12% Bis-Tris gels to resolve URM1 (~11 kDa) from conjugates (e.g., URM1-Ahp1 at ~35 kDa) .
Antibody validation: Compare multiple clones (e.g., Proteintech 15285-1-AP vs. Abcam EPR4809) across ≥3 biological replicates .